The Patient Protection and Affordable Care Act: Is it good or bad for oncology?

Authors

  • Hagop M. Kantarjian MD,

    Corresponding author
    1. Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas
    • Corresponding author: Hagop M. Kantarjian, MD, Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd, Unit 428, Houston, TX, 77030; Fax: (713) 794-4297; hkantarj@mdanderson.org

    Search for more papers by this author
  • David P. Steensma MD,

    1. Division of Hematologic Oncology, Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
    Search for more papers by this author
  • Donald W. Light PhD

    1. Edmond J. Safra Center for Ethics, Harvard University, Cambridge, Massachusetts
    Search for more papers by this author

Abstract

The Patient Protection and Affordable Care Act (ACA) has many flaws that need to be addressed, but it is better than what was. Oncologists should advocate for the ACA and work on improving it.

Ancillary